Company: MDCXW
Filing Date: 2025-04-25
Form Type: DRS
Source: 0001062993-25-007956
Chunk: 248

Company: Medicus Pharma Ltd.
Filing Date: 2025-04-25
Form: DRS
Chunk 248
---
                                                                                                                                                                                                                                        |
| 23.2* | Consent of MNP LLP                                                                                                                                                                                                                                                |
| 23.3* | Consent of Bennett Jones LLP (included in Exhibit 5.1)                                                                                                                                                                                                            |
| 23.4* | Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in Exhibit 5.2)                                                                                                                                                                                 |
| 24.1* | Powers of Attorney (included in the signature page to this Registration Statement)                                                                                                                                                                                |
| 107*  | Filing fee table                                                                                                                                                                                                                                                  |

____________________________

*To be filed by amendment.

+Indicates a management contract or compensatory plan.

#Schedules and certain other private or confidential information (as indicated therein) have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

† Certain private or confidential information (as indicated therein) have been redacted pursuant to Item 601(a)(6) of Regulation S-K.

<div align='center'>II-6</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in W. Conshohocken, Pennsylvania this day of , 2025.

| MEDICUS PHARMA LTD. |                                                       |
| By:                 |                                                       |
|                     | Name: Dr. Raza Bokhari                                
 Title: Executive Chairman and Chief Executive Officer |

<div align='center'>II-7</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

<div align='center'>POWERS OF ATTORNEY</div>

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Dr. Raza Bokhari or James Quinlan, or any of them, with full power to act alone, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead,